Functional characterisation of 13-bp deletion mutation (-1255 del) in the VWF gene promoter causing type 1 von willebrand disease

被引:0
|
作者
Othman, M. [1 ]
Chirinian, Y. [1 ]
Brown, C. [1 ]
Notely, C. [1 ]
Buckley, S. [2 ]
Waddington, S. N. [3 ]
Baker, A. H. [4 ]
Lillicrap, D. [1 ]
机构
[1] Queens Univ, Pathol & Mol Med, Kingston, ON, Canada
[2] Imperial Coll, Hematol, London, England
[3] Imperial Coll, Hematol, London, ON, Canada
[4] Univ Glasgow, Cardiovasc Res Ctr, Glasgow, Scotland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OC-TU-076
引用
收藏
页码:192 / 192
页数:1
相关论文
共 42 条
  • [31] Biochemical characterization of recombinant Von Willebrand factor (VWF) with a type 2B mutation (P1337L) coexpressed with a type 1 VWF defect (C275R): A complex molecular defect in a patient previously diagnosed with type 2A Von Willebrand disease (VWD).
    Baronciani, L
    Federici, AB
    Beretta, M
    Cozzi, G
    Canciani, MT
    Mannucci, PM
    BLOOD, 2004, 104 (11) : 293A - 293A
  • [32] Associations between the von willebrand factor gene (VWF) variant C.2771G > A (P.R924Q), von willebrand factor antigen (VWF:Ag) and FVIII activity (FVIII:C) levels and its role as a risk factor for type 1 von willebrand disease (VWD)
    Hickson, N.
    Hampshire, D. J.
    Winship, P. R.
    James, P. D.
    Peake, I. R.
    Goodeve, A. C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 11 - 11
  • [33] Characterisation of the p.A1461D mutation causing von Willebrand disease type 2B with severe thrombocytopenia, circulating giant platelets, and defective a-granule secretion
    Langer, Florian
    Obser, Tobias
    Oyen, Florian
    Spath, Brigitte
    Holstein, Katharina
    Greinacher, Andreas
    White, James G.
    Budde, Ulrich
    Bokemeyer, Carsten
    Schneppenheim, Reinhard
    THROMBOSIS AND HAEMOSTASIS, 2014, 111 (04) : 777 - 779
  • [34] A novel D235Y mutation in the GP1BA gene enhances platelet interaction with von Willebrand factor in an Iranian family with platelet-type von Willebrand disease
    Enayat, Said
    Ravanbod, Shirin
    Rassoulzadegan, Maryam
    Jazebi, Mohammad
    Tarighat, Shirin
    Ala, Fereydoun
    Emsley, Jonas
    Othman, Maha
    THROMBOSIS AND HAEMOSTASIS, 2012, 108 (05) : 946 - 954
  • [35] Polymorphic variation within the VWF gene contributes to the failure to detect mutations in patients historically diagnosed with type 1 von Willebrand disease from the MCMDM-1VWD cohort
    Hampshire, Daniel J.
    Burghel, George J.
    Goudemand, Jenny
    Bouvet, Laura C. S.
    Eikenboom, Jeroen C. J.
    Schneppenheim, Reinhard
    Budde, Ulrich
    Peake, Ian R.
    Goodeve, Anne C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (12): : 2163 - 2165
  • [36] A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease
    Stepanian, A
    Ribba, AS
    Lavergne, JM
    Fressinaud, E
    Juhan-Vague, I
    Mazurier, C
    Girma, JP
    Meyer, D
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (04) : 643 - 651
  • [37] Identification of p.W246L As a Novel Mutation in the GP1BA Gene Responsible for Platelet-Type von Willebrand Disease
    Woods, Adriana I.
    Sanchez-Luceros, Analia
    Bermejo, Emilse
    Paiva, Juvenal
    Alberto, Maria F.
    Grosso, Silvia H.
    Kempfer, Ana C.
    Lazzari, Maria A.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2014, 40 (02): : 151 - 160
  • [38] Variable phenotypic penetrance of von Willebrand factor gene Y1584C heterozygosity in type 1 von Willebrand disease families and its association with enhanced in vitro susceptibility to ADAMTS 13 mediated proteolysis.
    Lester, WA
    Bowen, DJ
    Cumming, A
    Collins, PW
    Watson, P
    Keeney, S
    Enayat, MS
    Keeling, D
    Pasi, KJ
    Bolton-Maggs, P
    Liesner, R
    Tate, C
    Peake, IR
    Hill, FGH
    BLOOD, 2003, 102 (11) : 311A - 311A
  • [39] Autosomal dominant type 1 von Willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effect
    Castaman, G
    Eikenboom, JCJ
    Missiaglia, E
    Rodeghiero, F
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 108 (04) : 876 - 879
  • [40] Fourteen Percent of Healthy African Americans Participating In the Zimmerman Program for the Molecular and Clinical Biology of VWD (ZPMCB VWD) Are Heterozygous for the VWF Gene Mutation H817Q Associated with Type 2N Von Willebrand Disease
    Friedman, Kenneth D.
    Bellissimo, Daniel B.
    Christopherson, Pamela A.
    Flood, Veronica H.
    Gill, Joan Cox
    Montgomery, Robert R.
    Haberichter, Sandra L.
    BLOOD, 2010, 116 (21) : 111 - 111